Swiss National Bank’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,250
| Closed | -$536K | – | 2581 |
|
|
2023
Q3 | $536K | Buy |
11,250
+270
| +2% | +$12.9K | ﹤0.01% | 2499 |
|
|
2023
Q2 | $1.05M | Buy |
10,980
+225
| +2% | +$21.6K | ﹤0.01% | 2264 |
|
|
2023
Q1 | $1.22M | Sell |
10,755
-1,230
| -10% | -$139K | ﹤0.01% | 2135 |
|
|
2022
Q4 | $1.34M | Buy |
11,985
+345
| +3% | +$38.6K | ﹤0.01% | 2157 |
|
|
2022
Q3 | $1.5M | Buy |
11,640
+4,070
| +54% | +$523K | ﹤0.01% | 2074 |
|
|
2022
Q2 | $519K | Sell |
7,570
-575
| -7% | -$39.4K | ﹤0.01% | 2602 |
|
|
2022
Q1 | $1.16M | Buy |
8,145
+605
| +8% | +$86.2K | ﹤0.01% | 2335 |
|
|
2021
Q4 | $1.26M | Hold |
7,540
| – | – | ﹤0.01% | 2340 |
|
|
2021
Q3 | $1.05M | Hold |
7,540
| – | – | ﹤0.01% | 2419 |
|
|
2021
Q2 | $3.6M | Buy |
7,540
+245
| +3% | +$117K | ﹤0.01% | 1724 |
|
|
2021
Q1 | $3M | Buy |
7,295
+355
| +5% | +$146K | ﹤0.01% | 1754 |
|
|
2020
Q4 | $3.4M | Buy |
+6,940
| New | +$3.4M | ﹤0.01% | 1605 |
|
|
2019
Q2 | – | Sell |
-1,805
| Closed | -$248K | – | 2561 |
|
|
2019
Q1 | $248K | Hold |
1,805
| – | – | ﹤0.01% | 2481 |
|
|
2018
Q4 | $163K | Buy |
1,805
+125
| +7% | +$11.3K | ﹤0.01% | 2528 |
|
|
2018
Q3 | $255K | Hold |
1,680
| – | – | ﹤0.01% | 2492 |
|
|
2018
Q2 | $289K | Hold |
1,680
| – | – | ﹤0.01% | 2514 |
|
|
2018
Q1 | $247K | Hold |
1,680
| – | – | ﹤0.01% | 2469 |
|
|
2017
Q4 | $341K | Hold |
1,680
| – | – | ﹤0.01% | 2479 |
|
|
2017
Q3 | $539K | Hold |
1,680
| – | – | ﹤0.01% | 2356 |
|
|
2017
Q2 | $380K | Buy |
1,680
+495
| +42% | +$112K | ﹤0.01% | 2476 |
|
|
2017
Q1 | $267K | Hold |
1,185
| – | – | ﹤0.01% | 2497 |
|
|
2016
Q4 | $235K | Hold |
1,185
| – | – | ﹤0.01% | 2539 |
|
|
2016
Q3 | $291K | Hold |
1,185
| – | – | ﹤0.01% | 2492 |
|
|
2016
Q2 | $688K | Buy |
1,185
+515
| +77% | +$299K | ﹤0.01% | 2180 |
|
|
2016
Q1 | $341K | Buy |
670
+160
| +31% | +$81.4K | ﹤0.01% | 2457 |
|
|
2015
Q4 | $358K | Buy |
+510
| New | +$358K | ﹤0.01% | 2419 |
|